Hunan Medoncare Pharmaceutical Co., Ltd. (referred to as Medoncare) was established in October 2010, located in national high-tech development zone, Changsha. Medoncare was founded by a group of returnee scientists with an international pharmaceutical industry background, we are committed to the development of original new drugs, improved new drugs, compound preparations, traditional Chinese medicine products with proprietary intellectual property rights(High-tech enterprise). Focusing on product upgrading brought by pharmaceutical technology innovation and product innovation brought by new drug development is the future key development path of Medoncare. Medoncare focuses on the research and development of technology and products, takes corresponding patent property rights protection as the core business, and takes the authorization, transfer, cooperative development and independent development of patents as the main business model. The leadership team consists of Chinese and American scientists and managers, the core technical team members have doctorates in the fields of medicine, pharmacy, chemistry and materials science, and have worked for many years in the pharmaceutical industry and medical institutions in the United States. After eight years of development, Medoncare has established an international research and development team, and established a technology research and development center of 6,000 square meters, which can simultaneously carry out the research and development of new drugs of traditional Chinese medicine and chemical drugs, biological research, process development, preparation research and pre-preparation research. It has great discoveries and innovative achievements in the fields of anti-swelling, immunological diseases, anti-virus, prostate diseases and orthopaedic diseases.